Powered by
Read the full press release from BusinessWire here. Imbed Biosciences Inc. (Imbed), a privately held biotech company emerging as a leader in the development of advanced therapies for burns, chronic ulcers and surgical wounds, announced today that it has closed…
Read the full press release from Promentis Pharmaceuticals here. Promentis Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing innovative therapies for neuropsychiatric disorders, today announced it has successfully completed a behavioral biomarker study for its lead compound, SXC-2023, and has finished enrolling…
Read the full press release on BusinessWire here. TAI Diagnostics, Inc., focused on developing innovative diagnostic tests for monitoring the health of transplanted organs, today announced the publication, “Effect of endomyocardial biopsy on levels of donor-specific cell-free DNA” in the October, 2019…
Read the full story from BizTimes here. Advocate Aurora Health broke ground Wednesday to celebrate the start of construction for its planned $228 million development in Mount Pleasant. The project will include a 198,000-square-foot medical center and 98,000-square-foot medical office building on…
Read the full story from Illumina here. October 21, 2019 In October 2014, Illumina Accelerator announced the inaugural class of companies to join the world’s first business accelerator focused on creating an innovation ecosystem for the genomics industry. Illumina Accelerator’s goal is…